An alternative approach that might perhaps result in a beneficial effect on both clinical signs and symptoms as well as joint destruction could be the suppression of Rac signaling in RA by compounds targeting both Rac1 and Rac2 signaling. This evidence concerns the gene AKT1 and rheumatoid arthritis.